Myosana Therapeutics
Pre-clinicalMyosana Therapeutics is one of the pioneering companies in non-viral gene therapy for neuromuscular and cardiac diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $4.5M
About
Myosana Therapeutics is one of the pioneering companies in non-viral gene therapy for neuromuscular and cardiac diseases.
RNA & Gene Therapy
Funding History
1Total raised:$4.5M
Seed$4.5MSep 15, 2021